Hiroshi Miyata
Papers
4
Total Citations
77
H-Index
3
About
Hiroshi Miyata is a leading figure in the advancement of robotic surgery for gastrointestinal malignancies, with a particular focus on gastric and rectal cancers. His research is centered on demonstrating the safety, efficacy, and oncologic outcomes of robotic approaches compared to traditional minimally invasive techniques. Miyata’s most influential work, a 2022 propensity score-matched analysis comparing robotic and laparoscopic gastrectomy for gastric cancer, has garnered 54 citations and provides critical evidence supporting the robotic platform’s perioperative benefits. He has also pushed the boundaries of surgical innovation, as seen in his 2022 report on a completely robotic total gastrectomy with thrombectomy and portal vein reconstruction for gastric cancer with portal vein tumor thrombus—a procedure traditionally requiring highly invasive laparotomy. More recently, his 2025 study on the learning curve for robot-assisted lateral lymph node dissection in lower rectal cancer offers valuable guidance for surgical training and adoption. With a growing body of work that includes analyses of three-year survival outcomes, Miyata’s contributions are shaping the future of robotic oncologic surgery, improving both technical feasibility and patient prognosis.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4